Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Sung-Hoon Jung, MD, Seong Young Kwon, Jung-Joon Min, Hee Seung Bom, Seo-Yeon Ahn, MD, Seung-Yeon Jung, Seung-Shin Lee, MD, Moo-Rim Park, MD, Deok-Hwan Yang, MD, Jae-Sook Ahn, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 4483.

https://doi.org/10.1182/blood-2018-99-112354

Published: 2018

Journal Articles

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Kyoung Ha Kim, Lee Jae Hoon, Mark Lee, Kim Hoon-Gu, Young Rok Do, Yong Park, MD PhD, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Won Seog Kim, Sung-Kyu Park, MD, Jong-Ho Won, Jee Hyun Kong, Moo-Rim Park, MD, Je-Jung Lee, Jae-Yong Kwak, Hye Jin Kang, MD PhD, Yeung-Chul Mun

Blood (2016) 128 (22): 3466.

https://doi.org/10.1182/blood.V128.22.3466.3466

Published: 2016

Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.

Blood (2012) 120 (21): 3106.

https://doi.org/10.1182/blood.V120.21.3106.3106

Published: 2012

Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis

Blood (2011) 118 (21): 2044.

https://doi.org/10.1182/blood.V118.21.2044.2044

Published: 2011

Journal Articles

Hematopoietic Stem Cell Repopulation Modulated by ROS-Detoxifying Enzymes,

Richard XuFeng, MD, Moo-Rim Park, MD, Weimin Miao, M.D., Ph.D., Hui Yu, MD, PhD, Michael W. Epperly, Ph.D., Joel S. Greenberger, MD, Tao Cheng, MD

Blood (2011) 118 (21): 4172.

https://doi.org/10.1182/blood.V118.21.4172.4172

Published: 2011

Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Blood (2010) 116 (21): 2272.

https://doi.org/10.1182/blood.V116.21.2272.2272

Published: 2010

Journal Articles

Association Between Genetic Polymorphism in DNA Repair Genes and Acute Myeloid Leukemia.

Hee Nam Kim, PhD, Nan young Kim, Li Yu, Huong Thi Thanh Tran, Yeo-Kyeoung Kim, Il-Kwon Lee, Deok-Hwan Yang, Je-Jung Lee, Hee-Je Kim, Woo-Sung Min, Moo-Rim Park, Deog Yeon Jo, Jong Ho Won, Jae-Yong Kwak, Hyeoung-Joon Kim

Blood (2009) 114 (22): 4131.

https://doi.org/10.1182/blood.V114.22.4131.4131

Published: 2009

Journal Articles

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Byung Woog Kang, M.D., Shi Nae Kim, M.D., Joon Ho Moon, M.D., Joo-Seop Jung, Goon-Jae Cho, Deog Yeon Jo, Yeo-Kyeoung Kim, Hyeoung Joon Kim, MD, Hun-Mo Ryoo, Hyeon Seok Eom, MD, PhD, Sang Min Lee, Young-Don Joo, Jong Ho Won, Moo-Rim Park, MD, Min Kyoung Kim, Myung Soo Hyun, MD, PhD, Sang Kyun Sohn, M.D.

Blood (2009) 114 (22): 3381.

https://doi.org/10.1182/blood.V114.22.3381.3381

Published: 2009

Journal Articles

Polymorphisms in Myeloid Cell Leukemia-1 and the Risk for Acute Myeloid Leukemia

Hee Nam Kim, PhD, Li Yu, Nan young Kim, Il-Kwon Lee, Yeo-Kyeoung Kim, Deok-Hwan Yang, Je-Jung Lee, MD, PhD, Hee-je Kim, Woo-Sung Min, Moo-Rim Park, MD, Deog-Yeon Jo, Jong-Ho Won, Jae-Yong Kwak, Hyeoung- Joon Kim

Blood (2008) 112 (11): 3977.

https://doi.org/10.1182/blood.V112.11.3977.3977

Published: 2008

Journal Articles

GST T1 and GST M1 Polymorphisms Are Associated with the Risk of Acute Myeloid Leukemia

Hee Nam Kim, PhD, Li Yu, Nan Young Kim, Il-Kwon Lee, Yeo-Kyeoung Kim, Deok-Hwan Yang, Je-Jung Lee, MD, PhD, Hee-Je Kim, Woo- Sung Min, Moo-Rim Park, MD, Deog-Yeon Jo, MD, PhD, Jong-Ho Won, Jae-Yong Kwak, Hyeoung Joon Kim, MD

Blood (2008) 112 (11): 3978.

https://doi.org/10.1182/blood.V112.11.3978.3978

Published: 2008

Journal Articles

Prognostic Significance of NQO1 Polymorphism and GST-M1 Deletion in De Novo Acute Myeloid Leukemia

Yeo-Kyeoung Kim, Hee-Je Kim, Woo-Sung Min, Jong- Ho Won, Deog-Yeon Jo, Moo-Rim Park, Hee-Nam Kim, Il-Kwon Lee, Jae-Sook Ahn, Deok-Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim

Blood (2008) 112 (11): 4846.

https://doi.org/10.1182/blood.V112.11.4846.4846

Published: 2008

Journal Articles

Case-Control Study Using Array-Based Genotyping Produced a Panel of Genes Associated with Risk to Acute Myelogenous Leukemia (AML).

Il-Kwon Lee, Hee Nam Kim, Yeo-Kyeoung Kim, Kyeong-Soo Park, Deok-Hwan Yang, Je-Jung Lee, Myung Geun Shin, Chan Choi, Hoon Kook, Tae Ju Hwang, Moo Rim Park, Deog Yeon Jo, Jong Ho Won, Hyeoung-Joon Kim

Blood (2007) 110 (11): 2384.

https://doi.org/10.1182/blood.V110.11.2384.2384

Published: 2007

Journal Articles

Functional Polymorphisms of Notch 4 and the Risk of Aplastic Anemia.

Hee Nam Kim, Yeo-Kyeoung Kim, II-Kwon Lee, Deok-Hwan Yang, Myung Geun Shin, Hoon Kook, Tai Ju Hwang, Moo Rim Park, Deog Yeon Jo, Jong Ho Won, HyeoungJoon Kim

Blood (2007) 110 (11): 1732.

https://doi.org/10.1182/blood.V110.11.1732.1732

Published: 2007

Journal Articles

Notch 4 Plymorphism Associated with Risk of Aplastic Anemia.

Hee Nam Kim, Jeong-Hwa Choi, Ju-Hyun Yun, Yeo-Kyeoung Kim, Il-Kwon Lee, Deok-Hwan Yang, Myung-Geun Shin, Hoon Kook, Tai Ju Hwang, Moo-Rim Park, Deog-Yeon Jo, Jong Ho Won, HyeoungJoon Kim

Blood (2006) 108 (11): 988.

https://doi.org/10.1182/blood.V108.11.988.988

Published: 2006

Journal Articles

Diagnostic Usefulness of JAK2 Mutation in Manistest or Latent Polycythemia Vera and Secondary Polycythemia.

Soo-Mee Bang, Eun Mi Nam, Jeong Yeal Ahn, Jae-Hoon Lee, Bong-Seog Kim, Seung-Hyun Nam, Hyun-Sook Chi, Young Uk Cho, Hyo Jung Kim, Dae Young Zang, Moo-Rim Park, Hyeok Shim, Jong Seok Lee, Jong-Ho Won, Doyeun Oh, Korean MPD Working Party

Blood (2006) 108 (11): 4901.

https://doi.org/10.1182/blood.V108.11.4901.4901

Published: 2006

Journal Articles

Polymorphisms of Thymidylate Synthase in the 5′- and 3′-Untranslated Regions Associated with Risk of Non-Hodgkin’s Lymphoma.

Hee Nam Kim, Huong Thi Thanh Tran, Il-Kwon Lee, Yeo-Kyeoung Kim, Deok-Hwan Yang, Je-Jung Lee, Myung-Geun Shin, Hoon Kook, Tai Ju Hwang, Moo Rim Park, Deog Yeon Jo, Jong Ho Won, HyeoungJoon Kim

Blood (2006) 108 (11): 2394.

https://doi.org/10.1182/blood.V108.11.2394.2394

Published: 2006

Journal Articles

Association of cis -Acting rs530 of the ETS2 Transcriptional Factor Gene with High-Risk Acute Myelogenous Leukemia (AML) and Allelic Expression Imbalance Assessment.

Il-Kwon Lee, Jeong-Hwa Choi, Hee Nam Kim, Yeo-Kyeoung Kim, Kyeong-Soo Park, Je-Jung Lee, Myung-Geun Shin, Chan Choi, Hoon Kook, Tai Ju Hwang, Moo-Rim Park, Deog-Yeon Jo, Jong-Ho Won, Hyeoung Joon Kim

Blood (2006) 108 (11): 2230.

https://doi.org/10.1182/blood.V108.11.2230.2230

Published: 2006

Journal Articles

The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse.

Yeo-Kyeoung Kim, Hee-Nam Kim, Il-Kwon Lee, Su-Mi Lee, Hyeok Shim, Moo-Rim Park, Kyeoung-Soo Park, Deok-Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim

Blood (2005) 106 (11): 4515.

https://doi.org/10.1182/blood.V106.11.4515.4515

Published: 2005

Journal Articles

Durable Remission of Acute Panmyelosis with Myelofibrosis Following Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation.

Moo-Rim Park, MD, Hyeok Shim, MD, Young-Jin Lee, MD

Blood (2005) 106 (11): 5305.

https://doi.org/10.1182/blood.V106.11.5305.5305

Published: 2005

Journal Articles

A Single Nucleotide Polymorphism and Its Haplotype of ZNF42 Transcriptional Modulator Gene Predisposes Individuals to High-Risk Acute Myelogenous Leukemia (AML).

Il-Kwon Lee, Jeong-Hwa Choi, Yu Ra Lee, Yeo-Kyeoung Kim, Hee Nam Kim, Kyeong-Soo Park, Je-Jung Lee, Myung Geun Shin, Chan Choi, Hoon Kook, Tai Ju Hwang, Moo Rim Park, Deog Yeon Jo, Jong Ho Won, Hyeoung-Joon Kim

Blood (2005) 106 (11): 4248.

https://doi.org/10.1182/blood.V106.11.4248.4248

Published: 2005

NARROW

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Hematopoietic Stem Cell Repopulation Modulated by ROS-Detoxifying Enzymes,

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Association Between Genetic Polymorphism in DNA Repair Genes and Acute Myeloid Leukemia.

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Polymorphisms in Myeloid Cell Leukemia-1 and the Risk for Acute Myeloid Leukemia

GST T1 and GST M1 Polymorphisms Are Associated with the Risk of Acute Myeloid Leukemia

Prognostic Significance of NQO1 Polymorphism and GST-M1 Deletion in De Novo Acute Myeloid Leukemia

Case-Control Study Using Array-Based Genotyping Produced a Panel of Genes Associated with Risk to Acute Myelogenous Leukemia (AML).

Functional Polymorphisms of Notch 4 and the Risk of Aplastic Anemia.

Notch 4 Plymorphism Associated with Risk of Aplastic Anemia.

Diagnostic Usefulness of JAK2 Mutation in Manistest or Latent Polycythemia Vera and Secondary Polycythemia.

Polymorphisms of Thymidylate Synthase in the 5′- and 3′-Untranslated Regions Associated with Risk of Non-Hodgkin’s Lymphoma.

Association of cis -Acting rs530 of the ETS2 Transcriptional Factor Gene with High-Risk Acute Myelogenous Leukemia (AML) and Allelic Expression Imbalance Assessment.

The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse.

Durable Remission of Acute Panmyelosis with Myelofibrosis Following Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation.

A Single Nucleotide Polymorphism and Its Haplotype of ZNF42 Transcriptional Modulator Gene Predisposes Individuals to High-Risk Acute Myelogenous Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only